British Journal of Cancer - Table of Contents alert Volume 115 Issue 11

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 115, Issue 11 (1273-1440) Published online 22 November 2016 In this issue Minireview Clinical Studies Translational Therapeutics Molecular Diagnostics Epidemiology Also new today Advance online publication Digital Edition Sign up for e-alerts Recommend to your library Web feed Subscribe Minireview Top In the Wnt-er of life: Wnt signalling in melanoma and ageing Amanpreet Kaur, Marie R Webster and Ashani T Weeraratna Br J Cancer 2016 115: 1273-1279; advance online publication, October 20, 2016; 10.1038/bjc.2016.332 Abstract | Full Text Clinical Studies Top Cessation of targeted therapy after a complete response in BRAF-mutant advanced melanoma: a case series Matteo S Carlino, Vito Vanella, Christina Girgis, Diana Giannarelli, Alex Guminski, Lucia Festino, Richard F Kefford, Alexander M Menzies, Georgina V Long and Paolo A Ascierto Br J Cancer 2016 115: 1280-1284; advance online publication, October 6, 2016; 10.1038/bjc.2016.321 Abstract | Full Text Incorporating multiparametric MRI staging and the new histological Grade Group system improves risk-stratified detection of bone metastasis in prostate cancer David Thurtle, Ray C J Hsu, Madhurima Chetan, Artitaya Lophatananon, Rachel Hubbard, Vincent J Gnanapragasam and Tristan Barrett Br J Cancer 2016 115: 1285-1288; advance online publication, November 1, 2016; 10.1038/bjc.2016.353 Abstract | Full Text Digoxin and prostate cancer survival in the Finnish Randomized Study of Screening for Prostate Cancer Kalle J Kaapu, Teemu J Murtola, Kirsi Talala, Kimmo Taari, Teuvo LJ Tammela and Anssi Auvinen Br J Cancer 2016 115: 1289-1295; advance online publication, October 18, 2016; 10.1038/bjc.2016.328 Abstract | Full Text Predicting poor prognosis recurrence in women with endometrial cancer: a nomogram developed by the FRANCOGYN study group Lobna Ouldamer, Sofiane Bendifallah, Gilles Body, Cyril Touboul, Olivier Graesslin, Emilie Raimond, Pierre Collinet, Charles Coutant, Vincent Lavoué, Jean Lévêque, Emile Daraï and Marcos Ballester for the Groupe de Recherche FRANCOGYN Br J Cancer 2016 115: 1296-1303; advance online publication, November 8, 2016; 10.1038/bjc.2016.337 Abstract | Full Text Effect of walking on circadian rhythms and sleep quality of patients with lung cancer: a randomised controlled trial Hui-Mei Chen, Chun-Ming Tsai, Yu-Chung Wu, Kuan-Chia Lin and Chia-Chin Lin Br J Cancer 2016 115: 1304-1312; advance online publication, November 3, 2016; 10.1038/bjc.2016.356 Abstract | Full Text Quality of life during olaparib maintenance therapy in platinum-sensitive relapsed serous ovarian cancer Jonathan A Ledermann, Philipp Harter, Charlie Gourley, Michael Friedlander, Ignace Vergote, Gordon Rustin, Clare Scott, Werner Meier, Ronnie Shapira-Frommer, Tamar Safra, Daniela Matei, Anitra Fielding, Bryan Bennett, David Parry, Stuart Spencer, Helen Mann and Ursula Matulonis Br J Cancer 2016 115: 1313-1320; advance online publication, November 8, 2016; 10.1038/bjc.2016.348 Abstract | Full Text Predictive factors of antiproliferative activity of octreotide LAR as first-line therapy for advanced neuroendocrine tumours Faidon-Marios Laskaratos, Martin Walker, Keval Naik, Emmanouil Maragkoudakis, Nikolaos Oikonomopoulos, Lee Grant, Tim Meyer, Martyn Caplin and Christos Toumpanakis Br J Cancer 2016 115: 1321-1327; advance online publication, November 3, 2016; 10.1038/bjc.2016.349 Abstract | Full Text Phase II study of chemoselection with docetaxel plus cisplatin and 5-fluorouracil induction chemotherapy and subsequent conversion surgery for locally advanced unresectable oesophageal cancer Tomoya Yokota, Ken Kato, Yasuo Hamamoto, Yasuhiro Tsubosa, Hirofumi Ogawa, Yoshinori Ito, Hiroki Hara, Takashi Ura, Takashi Kojima, Keisho Chin, Shuichi Hironaka, Takayuki Kii, Yasushi Kojima, Yasunori Akutsu, Hisayuki Matsushita, Kentaro Kawakami, Keita Mori, Yushi Nagai, Chika Asami and Yuko Kitagawa Br J Cancer 2016 115: 1328-1334; advance online publication, November 3, 2016; 10.1038/bjc.2016.350 Abstract | Full Text Translational Therapeutics Top Genotypes of CYP2C8 and FGD4 and their association with peripheral neuropathy or early dose reduction in paclitaxel-treated breast cancer patients Siu W Lam, Charlotte N Frederiks, Tahar van der Straaten, Aafke H Honkoop, Henk-Jan Guchelaar and Epie Boven Br J Cancer 2016 115: 1335-1342; advance online publication, October 13, 2016; 10.1038/bjc.2016.326 Abstract | Full Text MicroRNA 193b-3p as a predictive biomarker of chronic kidney disease in patients undergoing radical nephrectomy for renal cell carcinoma Francesco Trevisani, Michele Ghidini, Alessandro Larcher, Andrea Lampis, Hazel Lote, Paolo Manunta, Maria Teresa Sciarrone Alibrandi, Laura Zagato, Lorena Citterio, Giacomo Dell'Antonio, Cristina Carenzi, Giovambattista Capasso, Massimo Rugge, Paolo Rigotti, Roberto Bertini, Luciano Cascione, Alberto Briganti, Andrea Salonia, Fabio Benigni, Chiara Braconi, Matteo Fassan, Jens Claus Hahne, Francesco Montorsi and Nicola Valeri Br J Cancer 2016 115: 1343-1350; advance online publication, November 1, 2016; 10.1038/bjc.2016.329 Abstract | Full Text Molecular Diagnostics Top Downregulation of EGFR in hypoxic, diffusion-limited areas of squamous cell carcinomas of the head and neck Arnulf Mayer, Sebastian Zahnreich, Jürgen Brieger, Peter Vaupel and Heinz Schmidberger Br J Cancer 2016 115: 1351-1358; advance online publication, November 1, 2016; 10.1038/bjc.2016.336 Abstract | Full Text No association of CpG island methylator phenotype and colorectal cancer survival: population-based study Min Jia, Lina Jansen, Viola Walter, Katrin Tagscherer, Wilfried Roth, Esther Herpel, Matthias Kloor, Hendrik Bläker, Jenny Chang-Claude, Hermann Brenner and Michael Hoffmeister Br J Cancer 2016 115: 1359-1366; advance online publication, November 3, 2016; 10.1038/bjc.2016.361 Abstract | Full Text The FOXD3/miR-214/MED19 axis suppresses tumour growth and metastasis in human colorectal cancer G Y He, J L Hu, L Zhou, X H Zhu, S N Xin, D Zhang, G F Lu, W T Liao, Y Q Ding and L Liang Br J Cancer 2016 115: 1367-1378; advance online publication, November 3, 2016; 10.1038/bjc.2016.362 Abstract | Full Text Epidemiology Top Surgeon volume and 30 day mortality for brain tumours in England Matt Williams, Peter Treasure, David Greenberg, Andrew Brodbelt and Peter Collins on behalf of the (UK) National Cancer Information Network Brain Tumour Group Br J Cancer 2016 115: 1379-1382; advance online publication, October 20, 2016; 10.1038/bjc.2016.317 Abstract | Full Text Pathogenesis and progression of oesophageal adenocarcinoma varies by prior diagnosis of Barrett’s oesophagus Michael B Cook, Jennifer Drahos, Shannon Wood, Lindsey Enewold, Ruth Parsons, Neal D Freedman, Philip R Taylor, Winnie Ricker and Christian C Abnet Br J Cancer 2016 115: 1383-1390; advance online publication, October 25, 2016; 10.1038/bjc.2016.344 Abstract | Full Text Reproductive and hormonal factors in relation to survival and platinum resistance among ovarian cancer cases Amy L Shafrir, Ana Babic, Rulla M Tamimi, Bernard A Rosner, Shelley S Tworoger and Kathryn L Terry Br J Cancer 2016 115: 1391-1399; advance online publication, October 4, 2016; 10.1038/bjc.2016.316 Abstract | Full Text Risk of hospitalisation and death due to bone fractures after breast cancer: a registry-based cohort study Edoardo Colzani, Mark Clements, Anna L V Johansson, Annelie Liljegren, Wei He, Judith Brand, Jan Adolfsson, Tommy Fornander, Per Hall and Kamila Czene Br J Cancer 2016 115: 1400-1407; advance online publication, October 4, 2016; 10.1038/bjc.2016.314 Abstract | Full Text Short-term breast cancer survival in relation to ethnicity, stage, grade and receptor status: national cohort study in England Henrik Møller, Katherine Henson, Margreet Lüchtenborg, John Broggio, Jackie Charman, Victoria H Coupland, Elizabeth Davies, Ruth H Jack, Richard Sullivan, Peter Vedsted, Kieran Horgan, Neil Pearce and Arnie Purushotham Br J Cancer 2016 115: 1408-1415; advance online publication, October 25, 2016; 10.1038/bjc.2016.335 Abstract | Full Text Reproductive history and risk of colorectal adenocarcinoma in parous women: a Nordic population-based case–control study Tone Bjørge, Mika Gissler, Anne Gulbech Ording, Anders Engeland, Ingrid Glimelius, Maarit Leinonen, Henrik Toft Sørensen, Steinar Tretli, Anders Ekbom, Rebecca Troisi and Tom Grotmol Br J Cancer 2016 115: 1416-1420; advance online publication, October 4, 2016; 10.1038/bjc.2016.315 Abstract | Full Text Risk factors cannot explain the higher prevalence rates of precancerous colorectal lesions in men Elisabeth Waldmann, Georg Heinze, Arnulf Ferlitsch, Irina GessI, Daniela Sallinger, Philip Jeschek, Martha Britto-Arias, Petra Salzl, Elisabeth Fasching, Bernd Jilma, Michael Kundi, Michael Trauner and Monika Ferlitsch Br J Cancer 2016 115: 1421-1429; advance online publication, October 20, 2016; 10.1038/bjc.2016.324 Abstract | Full Text Main nutrient patterns and colorectal cancer risk in the European Prospective Investigation into Cancer and Nutrition study Aurélie Moskal, Heinz Freisling, Graham Byrnes, Nada Assi, Michael T Fahey, Mazda Jenab, Pietro Ferrari, Anne Tjønneland, Kristina EN Petersen, Christina C Dahm, Camilla Plambeck Hansen, Aurélie Affret, Marie-Christine Boutron-Ruault, Claire Cadeau, Tilman Kühn, Verena Katzke, Khalid Iqbal, Heiner Boeing, Antonia Trichopoulou, Christina Bamia, Androniki Naska, Giovanna Masala, Maria Santucci de Magistris, Sabina Sieri, Rosario Tumino, Carlotta Sacerdote, Petra H Peeters, Bas H Bueno-de-Mesquita, Dagrun Engeset, Idlir Licaj, Guri Skeie, Eva Ardanaz, Genevieve Buckland, José M Huerta Castaño, José R Quirós, Pilar Amiano, Elena Molina-Portillo, Anna Winkvist, Robin Myte, Ulrika Ericson, Emily Sonestedt, Aurora Perez-Cornago, Nick Wareham, Kay-Tee Khaw, Inge Huybrechts, Konstantinos K Tsilidis, Heather Ward, Marc J Gunter and Nadia Slimani Br J Cancer 2016 115: 1430-1440; advance online publication, October 20, 2016; 10.1038/bjc.2016.334 Abstract | Full Text Advertisement Blood Cancer Journal is an online-only, open access journal, publishing high quality research on hematologic malignancies and related disorders. Explore the benefits of submitting your next research article. Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to British Journal of Cancer. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2016 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.